Added to YB: 2026-10-05
Pitch date: 2026-10-01
SOFW.TA [bullish]
SofWave Medical Ltd.
+1.68%
current return
Author Info
No bio for this author
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally.
Market Cap
ILS 419.6M
Pitch Price
ILS 33.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
31.36
P/E
52.64
EV/Sales
3.67
Sector
Health Care Equipment and Supplies
Category
growth
Not So Fast - SofWave Medical Ltd.
SOFW.TA (hold): SofWave’s Q2 2026 performance offers little cause for concern: revenue grew 43%, with near-100%-margin PULSE sales up 52% and adjusted EBIT excluding non-recurring NASDAQ-listing costs up 67% to $3.6M. China approval adds a potentially meaningful market, though tougher Q3 comparisons and competition warrant monitoring. At 4.2x EV/sales, valuation still requires substantial growth; it is ~16.9x pro forma EV/EBIT if margins reach 25% within 2–3 years.
Read full article (3 min)